Mayo Clinic researchers collaborated on a new study led by Eli Lilly showing that the drug abemaciclib improves survival for people with high-risk, early-stage breast cancer.
This article was originally published on MedicalXpress.com
New drug study shows improved survival for early breast cancer
You may also be interested in:
The Latest
Microneedling Services in Edmonton: Benefits, Treatment Cost, and How It Works
Microneedling is a revolutionary skincare treatment that has gained popularity in recent years due to its numerous benefits, including reducing the appearance of scars, wrinkles, and acne, and promoting collagen production. Edmonton, the bustling capital […]
The Latest
5 Popular Supplements in Canada for Optimal Health and Wellness
As a health and wellness enthusiast, I have always been interested in the role of supplements in promoting optimal health. In Canada, there are many supplements available on the market, each with different benefits and […]
The Latest
Will a nutritional supplement help you run better?
Whether you jog to keep fit or compete in marathons, the physically demanding sport of running can deplete the body of essential nutrients. During a race like a half-marathon, a runner’s metabolism — or ability […]
Read More:
-
A Concordia-led research team has created one of the first reference charts showing how children’s adipose (fat) and muscle levels change with age and sex—a [...]
-
In 2019, Children’s Hospital Los Angeles was part of a multi-institution collaboration that was the first in the Western U.S. to perform a completely laparoscopic [...]
-
Through the 1990s and early 2000s, guidelines for treating a concussion called for complete mental and physical rest. Current guidelines recommend a gradual resumption of [...]
